Boston Children's Hospital, Dana-Farber Cancer Institute.

Boston, Massachusetts 02215

1 studies enrolling now · 3 studies all time

What they study most

Acute Graft vs Host Disease, Adverse Effects, Allogeneic Bone Marrow Transplantation, Ewing Sarcoma, Neuroblastoma

Studies at this site

• NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial — Recruiting now
• Pediatric GVHD Low Risk Steroid Taper Trial — Completed
• SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients — Completed